Loading data for CDNA — first visit, this takes a few seconds.

알림

CareDx Inc. (CDNA)

NasdaqGM: CDNA · 실시간 가격 · USD

46.18

-0.20 (-0.43%)

종가 기준: Aug 19, 2026, 5:11 PM

-0.43% (1D)

데이터 없음

매수호가	33.74
시가총액	2.43B
매출 (ttm)	458.09M
순이익 (ttm)	111.01M
베타	2.42
EPS (ttm)	2.07
P/E (ttm)	22.6
선행 P/E	34.69
P/B (ttm)	5.69
P/S (ttm)	5.31
Earnings Date	Nov 3, 2026

매도호가	60.27
거래량	840,097
평균 거래량 (20일)	1,037,212
시가	45.68
전일 종가	46.38
일중 범위	44.80 - 46.52
52주 범위	11.27 - 49.76
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

CDNA 소개

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA so...

[더 보기]

산업 Diagnostics & Research

섹터 Healthcare

IPO 일자 Jul 17, 2014

직원 수 761

상장 거래소 NasdaqGM

티커 CDNA

웹사이트 https://caredx.com

전체 기업 정보

재무 실적

2025년 CareDx의 매출은 379.81M로, 전년 333.79M 대비 13.79% 증가했습니다. 순이익은 -21.35M로, -140.64% 감소했습니다.

재무제표

어닝 서프라이즈

CareDx가 Jul 30, 2026에 분기 실적을 발표했습니다:

매출 $131.95M 예상치 하회 $0, 및 52.23% 전년 대비 성장.

EPS 0.37 예상치 상회 0.14, 및 270.00% 전년 대비 성장.

다음 실적 발표

CareDx Inc.의 실적 발표 예정일은 Nov 3, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

1주 전 · Insider Monkey

Baron Discovery Fund Gains from Strategic Accumulation of CareDx (CDNA)

Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Discovery Fund”. A copy of the letter is available to download here. Baron Discovery Fund appreciat...

1주 전 · Barchart

CareDx Stock Is Up 300% Over the Past Year. Here’s How Much Upside Is Left.

CareDx (CDNA) has surged 300% over the past year, driven by robust technical momentum and strong buy signals. CDNA is rated a “Strong Buy” by several analysts, with consensus price targets suggesting ...

2주 전 · Stocktwits

SNOW, CDNA Stocks Hit Fresh 52-Week Highs – What’s Driving Investor Optimism Today?

Snowflake and CareDx received favorable reviews from Wall Street firms, following better-than-expected second-quarter prints and bullish momentum across AI products, respectively.

2주 전 · Motley Fool

Why CareDx Stock Jumped Today

The diagnostics leader is accelerating the trend toward precision medicine.

2주 전 · Investor's Business Daily

Medical Test Name Explodes To A High After Earnings

A bank stock hits an all-time high while a medical test provider reaches a buy point of an unusual bullish chart pattern.

2 페이지 중 1